Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA

 SummaryNewsCalendarCompanyFinancials 
Company
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on ARDEA BIOSCIENCES, INC.
2012 AstraZeneca hungry to refill medicine cabinet
2012DJAstraZeneca Completes Acquisition of Ardea Biosciences
2012 GSK goes hostile with $2.6 billion Human Genome offer
2012 Biotech targets fight back as Big Pharma circles
2012 ARDEA BIOSCIENCES, INC. : Securities Lawyers at Goldfarb LLP Seeking More Money,..
2012 Warner Chilcott to explore sale of company
2012 ARDEA BIOSCIENCES, INC. : Law Office of Brodsky & Smith, LLC Announces Investiga..
2012DJPharma M&A Surge Spurred By Necessity And Opportunity
2012 AstraZeneca CEO quits as drug sales tumble
2012 Watson to buy Actavis for at least $5.6 billion
More news
Sector news : Bio Therapeutic Drugs
09/20DJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
09/15 Drug industry on tenterhooks as Maryland price-gouging law nears
09/07 New AstraZeneca, Amgen drug looks strong rival in severe asthma
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag -- Update
08/30DJFDA Approves Pioneering Cancer Treatment With $475,000 Price Tag
More sector news : Bio Therapeutic Drugs
Income Statement Evolution
Sector and Competitors
1st jan.Capitalization (M$)
ARDEA BIOSCIENCES, INC.0
AMGEN27.65%135 544
CELGENE CORPORATION24.22%112 572
GILEAD SCIENCES15.37%108 744
REGENERON PHARMACEUTICALS18.08%46 367
VERTEX PHARMACEUTICALS106.41%38 136